All Stories

  1. Lipoprotein(a) in Atherosclerotic Diseases: From Pathophysiology to Diagnosis and Treatment
  2. Lipoprotein (a) levels and Abdominal Aortic Aneurysm. A Systematic Review and Meta-analysis
  3. The Anti-Inflammatory Effect of Novel Antidiabetic Agents
  4. Interleukin-1 in Coronary Artery Disease
  5. Vaccination Against SARS-CoV-2 Protects from COVID-19-induced Endothelial Dysfunction
  6. Evaluation of the Perceptions, Attitudes and Practices among Greek Non-Professional Athletes Visiting a Public Hospital during March 2022, towards COVID-19 Vaccination and Its Consequences on Sports Training and Sports Activity
  7. The effect of stress management in patients post-acute myocardial infarction
  8. Impaired left ventricular deformation and ventricular-arterial coupling in post-COVID-19: association with autonomic dysregulation
  9. COVID-19, Endothelium and the Cardiometabolic Patient: A Possible Role for Capillary Leak Syndrome
  10. Granulocyte Colony-Stimulating Factor Ameliorates Endothelial Activation and Thrombotic Diathesis Biomarkers in a Murine Model of Hind Limb Ischemia
  11. Percutaneous Treatment Approaches in Atrial Fibrillation: Current Landscape and Future Perspectives
  12. Pericoronary fat attenuation index—a new imaging biomarker and its diagnostic and prognostic utility: a systematic review and meta-analysis
  13. Association of Growth Differentiation Factor 15 with Arterial Stiffness and Endothelial Function in Subpopulations of Patients with Coronary Artery Disease: A Proof-of-Concept Study
  14. Non-Invasive Modalities in the Assessment of Vulnerable Coronary Atherosclerotic Plaques
  15. The Role of Endothelial Related Circulating Biomarkers in COVID-19. A Systematic Review and Meta-analysis
  16. The Role of Cell-derived Microparticles in Cardiovascular Diseases: Current Concepts
  17. Increased Influenza Vaccination Coverage among Members of the Athens Medical Association Amidst COVID-19 Pandemic
  18. Expression of Tissue microRNAs in Ascending Aortic Aneurysms and Dissections
  19. Evaluation of Knowledge, Attitudes and Practices Related to Self-Testing Procedure against COVID-19 among Greek Students: A Pilot Study
  20. Factors Associated with Platelet Activation-Recent Pharmaceutical Approaches
  21. The association of diabetes mellitus with carotid atherosclerosis and arterial stiffness in the Corinthia study
  22. The Association of Physical Activity with Arterial Stiffness and Inflammation: Insight from the “Corinthia” Study
  23. A case report of left ventricular thrombus formation following aggressive decongestion treatment
  24. Genetic Predisposition and Inflammatory Inhibitors in COVID-19: Where Do We Stand?
  25. Association of arterial stiffness with functional parameters in patients with systolic heart failure: Data from the Corinthia study
  26. Atrial Fibrillation: Pathogenesis, Predisposing Factors, and Genetics
  27. Inflammation in Coronary Microvascular Dysfunction
  28. MicroRNAs as Biomarkers in Hypertrophic Cardiomyopathy: Current State of the Art
  29. Inflammatory Mediators of Platelet Activation: Focus on Atherosclerosis and COVID-19
  30. Sex Differences in Clinical Outcomes of Patients with Stable Coronary Artery Disease after Percutaneous Coronary Intervention
  31. MicroRNAs in the Management of Heart Failure
  32. Risk factors profile of young and older patients with myocardial infarction
  33. Inflammatory Mechanisms Contributing to Endothelial Dysfunction
  34. Inflammatory Mechanisms in COVID-19 and Atherosclerosis: Current Pharmaceutical Perspectives
  35. The Hellenic Journal of Cardiology: a 64-year voyage of discovery from the cradle of European civilization to the world
  36. Regulation of Long Non-Coding RNAs by Statins in Atherosclerosis
  37. The Effect of DPP-4i on Endothelial Function and Arterial Stiffness in Patients with Type 2 Diabetes: A Systematic Review of Randomized Placebo-controlled Trials
  38. Novel Antidiabetic Agents: Cardiovascular and Safety Outcomes
  39. Association of Soluble Suppression of Tumorigenesis-2 (ST2) with Endothelial Function in Patients with Ischemic Heart Failure
  40. Pro-inflammatory Cytokines in Acute Coronary Syndromes
  41. Arterial stiffness and microvascular disease in type 2 diabetes
  42. “The role of intracoronary administration of stem cells on myocardial reperfusion injury”
  43. Hospital attendance and admission trends for cardiac diseases during the COVID-19 outbreak and lockdown in Greece
  44. High-Intensity Endurance and Strength Training in Water Polo Olympic Team Players: Impact on Arterial Wall Properties
  45. Antithrombotic Treatment in Diabetes Mellitus: A Review of the Literature about Antiplatelet and Anticoagulation Strategies Used for Diabetic Patients in Primary and Secondary Prevention
  46. Antithrombotic Therapy in Carotid Artery Disease
  47. Current Antithrombotic Therapy: Beyond Coronary Artery Disease
  48. Proposed algorithm for return to sports in competitive athletes who have suffered COVID-19
  49. Development of a risk score for early saphenous vein graft failure: An individual patient data meta-analysis
  50. A reappraisal of the role of transthoracic ultrasound in the era of COVID-19. Patient evaluation through new windows
  51. Relationship between whole grain consumption and arterial stiffness. Results of the Corinthia cross-sectional study
  52. Acute Coronary Syndrome with Non-ruptured Plaques (NONRUPLA): Novel Ideas and Perspectives
  53. Cardiovascular disease and socioeconomic status
  54. Alirocumab and evolocumab: an indirect comparison of cardiovascular benefits
  55. Endothelial dysfunction and impaired arterial wall properties in patients with retinal vein occlusion
  56. MicroRNAs in Cardiovascular Disease
  57. The Greek study in the effects of colchicine in COvid-19 complications prevention (GRECCO-19 study): Rationale and study design
  58. Coronary Artery Disease and Endothelial Dysfunction: Novel Diagnostic and Therapeutic Approaches
  59. Mir-335-5p as a Potential Regulator of LRP1 Expression in Abdominal Aortic Aneurysm
  60. Acute exposure to diesel affects inflammation and vascular function
  61. Aortic regurgitation in competitive athletes: The role of multimodality imaging for clinical decision-making
  62. Diagnostic performance of electrocardiographic criteria in echocardiographic diagnosis of different patterns of left ventricular hypertrophy
  63. The aetiology of death for marathon runner Phidippides?
  64. Reply: Possible Effect of Alcohol Consumption on Aortic Dilatation by Inducing the Renin–Angiotensin–Aldosterone System
  65. Aortic stiffening is associated with increased left ventricular mass in women but not in men
  66. Breakfast association with arterial stiffness and carotid atherosclerotic burden. Insights from the ‘Corinthia’ study
  67. Galectin-3 and Arterial Stiffness in Patients with Heart Failure: A Pilot Study
  68. The influence of resting heart rate on pulse wave velocity measurement is mediated by blood pressure and depends on aortic stiffness levels: insights from the Corinthia study
  69. Pseudoexfoliative Glaucoma, Endothelial Dysfunction, and Arterial Stiffness
  70. Alcohol Consumption and Aortic Root Dilatation: Insights from the Corinthia Study
  71. Arterial stiffness and subclinical aortic damage of reclassified subjects as stage 1 hypertension according to the new 2017 ACC/AHA blood pressure guidelines
  72. Atrial Fibrillation: Biomarkers Determining Prognosis
  73. Biomarkers Determining Prognosis of Atrial Fibrillation Ablation
  74. Biomarkers in Atrial Fibrillation and Heart Failure
  75. MicroRNAs in Atrial Fibrillation
  76. Galectin-3
  77. Cardiovascular effects of electronic cigarettes: A systematic review and meta-analysis
  78. The effect of diet, lifestyle and psychological factors in the prognosis of ischemic heart failure
  79. Hyponatremia in patients with atrial fibrillation and heart failure: The difficult triangle
  80. Vitamin D: A cardiovascular risk biomarker or a treatment target?
  81. Cancer Therapeutics-Related Cardiovascular Complications. Mechanisms, Diagnosis and Treatment
  82. Heart failure a cluster of comorbidities or a unique entity?
  83. Associations between Adiponectin Gene Variability, Proinflammatory and Angiogenetic Markers: Implications for Microvascular Disease Development in Type 2 Diabetes Mellitus?
  84. The impact of sedentary behavior patterns on carotid atherosclerotic burden: Implications from the Corinthia epidemiological study
  85. The Role of Inflammation in Diabetes: Current Concepts and Future Perspectives
  86. Effects of Newer Antidiabetic Drugs on Endothelial Function and Arterial Stiffness: A Systematic Review and Meta-Analysis
  87. The association among biomarkers of renal and heart function in patients with heart failure: the role of NGAL
  88. Coronary Microcirculation and the No-reflow Phenomenon
  89. Myocardial performance versus exercise tolerance. What matters the most in patients with heart failure?
  90. The Impact of Omega 3 Fatty Acids in Atherosclerosis and Arterial Stiffness: An Overview of their Actions
  91. Polymorphism Gln27Glu of β2 Adrenergic Receptors in Patients with Ischaemic Cardiomyopath
  92. Inflammation: A pathogenetic mechanism or a mediator, linking risk factors and cardiovascular disease?
  93. Non-natriuretic peptide biomarkers in heart failure with preserved and reduced ejection fraction
  94. Effects of omega-3 polyunsaturated fatty acids on fibrosis, endothelial function and myocardial performance, in ischemic heart failure patients
  95. Circulating microparticles: Simply a research tool or a candidate clinical meaningful biomarker?
  96. Local Low Shear Stress and Endothelial Dysfunction in Patients With Nonobstructive Coronary Atherosclerosis
  97. Impact of “high” implantation on functionality of self-expandable bioprosthesis during the short- and long-term outcome of patients who undergo transcatheter aortic valve implantation: Is high implantation beneficial?
  98. Anti-inflammatory agents in peripheral arterial disease
  99. Coronary versus carotid artery plaques. Similarities and differences regarding biomarkers morphology and prognosis
  100. Editorial overview: Cardiovascular and renal: Novel therapies in peripheral artery disease
  101. Peripheral artery disease: a micro-RNA-related condition?
  102. Predictors of switching from nonsteroidal anti-inflammatory drugs to corticosteroids in patients with acute pericarditis and impact on clinical outcome
  103. Interrelationship between diabetes mellitus and heart failure: the role of peroxisome proliferator-activated receptors in left ventricle performance
  104. Echocardiography for the management of patients with biventricular pacing: Possible roles in cardiac resynchronization therapy implementation
  105. Statins and Contrast-Induced Nephropathy: A Systematic Review and Meta-Analysis
  106. Statins in Aortic Disease
  107. Prognostic significance of arterial stiffness and osteoprotegerin in patients with stable coronary artery disease
  108. 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomographic Imaging Detects Aortic Wall Inflammation in Patients With Repaired Coarctation of Aorta
  109. Flow-Mediated Dilation of Brachial Artery as a Screening Tool for Anthracycline-Induced Cardiotoxicity
  110. Statins and inflammation in cardiovascular disease
  111. Statins and left ventricular function
  112. Statins in Stable Angina Pectoris
  113. Statins in Aortic Stenosis
  114. Long-term endothelial dysfunction after trans-radial catheterization: A meta-analytic approach
  115. Western Dietary Pattern Is Associated With Severe Coronary Artery Disease
  116. Redox State in Atrial Fibrillation Pathogenesis and Relevant Therapeutic Approaches
  117. Macrovascular function indices for the prediction of diabetic retinopathy development in patients with type 2 diabetes
  118. Antiplatelet and Anticoagulation Therapy in Structural Heart Disease Interventions Beyond TAVI
  119. Genetics in the Clinical Decision of Antiplatelet Treatment
  120. Beneficial Effects of Sildenafil on Tissue Perfusion and Inflammation in a Murine Model of Limb Ischemia and Atherosclerosis
  121. Impact of balloon aortic valvuloplasty on transcatheter aortic valve implantation with self-expandable valve
  122. Genotyping, Platelet Activation, and Cardiovascular Outcome in Patients after Percutaneous Coronary Intervention: Two Pieces of the Puzzle of Clopidogrel Resistance
  123. Prognostic implications of epicardial fat volume quantification in acute pericarditis
  124. Established and novel treatment options in acute myocarditis, with or without heart failure
  125. Correlation of CoreValve implantation ‘true cover index’ with short and mid-term aortic regurgitation: A novel index
  126. The impact of T786C and G894T polymorphisms of eNOS on vascular endothelial growth factor serum levels in type 2 diabetes patients
  127. Effects of transradial coronary catheterization on systemic and local vascular endothelial function and inflammatory process
  128. Usefulness of C-Reactive Protein as a Predictor of Contrast-Induced Nephropathy After Percutaneous Coronary Interventions in Patients With Acute Myocardial Infarction and Presentation of a New Risk Score (Athens CIN Score)
  129. Novel risk factors’ hunting. Lessons from the study of older olds
  130. The effect of in-hospital acquired thrombocytopenia on the outcome of patients with acute coronary syndromes: A systematic review and meta-analysis
  131. The prognostic role of C-reactive protein after myocardial infarction in patients with normal or mildly impaired left ventricle systolic function
  132. Dual or Single Antiplatelet Therapy After Transcatheter Aortic Valve Implantation? A Systematic Review and Meta-Analysis
  133. Targeting percutaneous cardiovascular interventions at all who will benefit the most: The reality of the Eastern European countries
  134. The impact of dietary flavonoid supplementation on smoking-induced inflammatory process and fibrinolytic impairment
  135. Duration of Dual Antiplatelet Therapy after Coronary Stenting
  136. Acute effects of different types of aerobic exercise on endothelial function and arterial stiffness
  137. Characterization of vascular phenotype in patients with coronary artery ectasia: The role of endothelial dysfunction
  138. The Interaction Between Gender and Diabetes Mellitus in the Coronary Heart Disease Risk
  139. Antiplatelet Therapy in Acute Coronary Syndromes. Evidence Based Medicine
  140. Incessant pericarditis following dual-chamber cardioverter defibrillation device implantation
  141. Environment and cardiovascular disease: rationale of the Corinthia study
  142. Do we really need novel echocardiographic modalities to confirm the superiority of the intact His-Purkinje conduction system over pacing modes?
  143. Impact of C34T P2Y12 ADP receptor polymorphism and smoking status on cardiovascular outcome in coronary artery disease patients receiving clopidogrel
  144. Impairment of arterial elastic properties and elevated circulating levels of transforming growth factor-beta in subjects with repaired coarctation of aorta
  145. Basic Mechanisms in Atherosclerosis: The Role of Calcium
  146. Inflammatory cytokines in atherosclerosis: current therapeutic approaches
  147. The Acute Impact of Different Types of Aerobic Exercise on Arterial Wave Reflections and Inflammation
  148. Atherogenesis and hyperlipidemia a not straightforward association: We really need a novel biomarker?
  149. Different Prognostic Significance of Cardiac Troponin at Presentation and Peak Cardiac Troponin in Patients with Non-ST Segment Elevation Myocardial Infarction
  150. Impact of Laparoscopic Sleeve Gastrectomy on Weight Loss and Associated Comorbidities in Adolescents and Young Adults
  151. Real-time three-dimensional echocardiography: never before clinical efficacy looked so picturesque
  152. Clopidogrel response variability is associated with endothelial dysfunction in coronary artery disease patients receiving dual antiplatelet therapy
  153. Arterial Wall Elastic Properties and Endothelial Dysfunction in the Diabetic Foot Syndrome in Patients With Type 2 Diabetes
  154. The role of microRNAs in coronary artery disease: From pathophysiology to diagnosis and treatment
  155. Vascular function and ocular involvement in sarcoidosis
  156. Genetic testing and antiplatelet treatment: Still way to go?
  157. Atorvastatin treatment improves endothelial function through endothelial progenitor cells mobilization in ischemic heart failure patients
  158. Flow-mediated dilation: Is it just a research tool or a useful biomarker for cardiovascular prognosis
  159. An unusual case of a three coronary artery spasm
  160. Role of Endothelial Dysfunction and Arterial Stiffness in the Development of Diabetic Retinopathy: Figure 1
  161. Reply: Long term impact of CPAP on myocardial function in OSA. Always measurable cardiac index?
  162. Endothelial dysfunction in conduit arteries and in microcirculation. Novel therapeutic approaches
  163. Impact of C34T P2Y12 genotype on endothelial function and arterial stiffness in patients after percutaneous coronary intervention receiving clopidogrel
  164. Impact of folic acid administration in homocysteine levels, inflammation and in atherosclerotic plaque area in apoE deficient mice
  165. Oxidative Stress and Early Atherosclerosis: Novel Antioxidant Treatment
  166. High platelet reactivity is associated with vascular function in patients after percutaneous coronary intervention receiving clopidogrel
  167. Segmental myocardial hypokinesis and hypertrophy as initial echocardiographic presentation of myocarditis
  168. Combined effects of smoking and interleukin-6 and C-reactive protein genetic variants on endothelial function, inflammation, thrombosis and incidence of coronary artery disease
  169. Vascular effects of circulating CD4-T cells in patients with unstable angina
  170. Pro-Inflammatory Interleukin Genotypes Potentiate Early and Advanced Atherosclerosis Differently
  171. Impact of continuous positive airway pressure treatment on myocardial performance in patients with obstructive sleep apnea. A conventional and tissue Doppler echocardiographic study
  172. Cystatin-C serum levels and vascular function in heart failure
  173. Divergent effects of folic acid administration on inflammatory status and cholesterol levels in apoE deficient mice
  174. The Natural History of Multifocal Atrial Rhythms in Elderly Outpatients: Insights from the “Ikaria Study”
  175. The impact of AMPD1 gene polymorphism on vascular function and inflammation in patients with coronary artery disease
  176. Novel biomarkers in heart failure: usefulness in clinical practice
  177. Omega-3 PUFAs improved endothelial function and arterial stiffness with a parallel antiinflammatory effect in adults with metabolic syndrome
  178. Statins in heart failure—With preserved and reduced ejection fraction. An update
  179. Vitamin D serum levels are associated with cardiovascular outcome in coronary artery disease
  180. Favorable Effects of Concord Grape Juice on Endothelial Function and Arterial Stiffness in Healthy Smokers
  181. Serum osteoprotegerin and osteopontin levels are associated with arterial stiffness and the presence and severity of coronary artery disease
  182. The impact of CYP2C19 genotype on cardiovascular events and platelet reactivity in patients with coronary artery disease receiving clopidogrel
  183. Long-Term Fish Intake Preserves Kidney Function in Elderly Individuals: The Ikaria Study
  184. MicroRNAs: Novel Diagnostic and Prognostic Biomarkers in Atherosclerosis
  185. Novel Biomarkers Assessing Endothelial Dysfunction: Role of microRNAs
  186. MicroRNAs: Biomarkers for Cardiovascular Disease in Patients with Diabetes Mellitus
  187. Diagnostic and Therapeutic Potentials of microRNAs in Heart Failure
  188. MicroRNAs in the Diagnosis and Treatment of Unstable Angina
  189. MicroRNAs in Cardiovascular Therapeutics
  190. Effects of omega-3 fatty acids on endothelial function, arterial wall properties, inflammatory and fibrinolytic status in smokers: A cross over study
  191. Flavonoids in Atherosclerosis: An Overview of Their Mechanisms of Action
  192. Dose-dependent effects of short term atorvastatin treatment on arterial wall properties and on indices of left ventricular remodeling in ischemic heart failure
  193. Consumption of a boiled Greek type of coffee is associated with improved endothelial function: The Ikaria Study
  194. Genetic Predisposition to Left Ventricular Hypertrophy and the Potential Involvement of Cystatin-C in Untreated Hypertension
  195. Aortic elastic properties and cognitive function in elderly individuals: The Ikaria Study
  196. Low Total Testosterone Levels are Associated With the Metabolic Syndrome in Elderly Men: The Role of Body Weight, Lipids, Insulin Resistance, and Inflammation; The Ikaria Study
  197. Aortic artery distensibility shows inverse correlation with heart rate variability in elderly non-hypertensive, cardiovascular disease-free individuals: the Ikaria Study
  198. Comparable effects of pioglitazone and perindopril on circulating endothelial progenitor cells, inflammatory process and oxidative stress in patients with diabetes mellitus
  199. Adiponectin and Cardiovascular Disease: Mechanisms and New Therapeutic Approaches
  200. Genetic polymorphism M235T of angiotensinogen: Effects on endothelial function and arterial stiffness in hypertensives
  201. Novel Biomarkers Assessing the Calcium Deposition in Coronary Artery Disease
  202. Asymmetric dimethylarginine (ADMA): Is really a biomarker for cardiovascular prognosis?
  203. Cross-sectional relationship of a Mediterranean type diet to diastolic heart function in chronic heart failure patients
  204. Anti-tumor necrosis factor alpha treatment with adalimumab improves significantly endothelial function and decreases inflammatory process in patients with chronic psoriasis
  205. Distinct role of electrocardiographic criteria in echocardiographic diagnosis of left ventricular hypertrophy according to age, in the general population
  206. Gender variation of exercise-induced anti-arrhythmic protection: the Ikaria Study
  207. Association of Sarcoidosis With Endothelial Function, Arterial Wall Properties, and Biomarkers of Inflammation
  208. The association between glaucoma, vascular function and inflammatory process